Products in category "Hemostaseology Human Plasmas"

Name
Activated partial thromboplastin time (aPTT) plasma, pathological and normal
Afibrinogenemia plasma, acquired
Afibrinogenemia plasma, congenital
Alpha-2 antiplasmin deficient plasma (acquired)
Alpha-2 antiplasmin deficient plasma (congenital)
Alpha-2 antiplasmin depleted plasma
Anti-cardiolipin antibody (ACA) plasma
Anti-prothrombin plasma
Anti-β2Gp1 antibody plasma
Antiphospholipid Antibody Positive Plasma
Antithrombin deficient plasma (acquired)
Antithrombin deficient plasma (congenital)
D-Dimer positive plasma, DIC (disseminated intravasular coagulation)
D-Dimer positive plasma, in DDU or in FEU (600 - 80 000 micrograms FEU)
D-Dimer positve plasma, deep vein thrombosis (DVT) / pulmonary embolism (PE)
Direct thrombin (FIIa) inhibitor, plasma: Argatroban
Direct thrombin (FIIa) inhibitor, plasma: Bivalirudin (Angiox)
Direct thrombin (FIIa) inhibitor, plasma: Lepirudin (Refludan)
Dysfibrinogenemia plasma, acquired
Dysfibrinogenemia plasma, congenital
Factor II (prothrombin) deficient plasma (acquired)
Factor II (prothrombin) deficient plasma (congenital)
Factor II (prothrombin) high plasma (acquired)
Factor II (prothrombin) high plasma (congenital)
Factor II high plasma (G20210A FII mutation)
Factor IX deficient plasma (acquired)
Factor IX high plasma (acquired)
Factor IX inhibitor plasma (Bethesda)
Factor V Leiden plasma, heterozygous (PCR, APC ratio)
Factor V Leiden plasma, homozygous (PCR, APC ratio)
Factor V deficient plasma (acquired)
Factor V deficient plasma (congenital)
Factor V high plasma (acquired)
Factor VII deficient plasma (acquired)
Factor VII deficient plasma (congenital)
Factor VII high plasma (acquired)
Factor VIII deficient plasma (acquired)
Factor VIII deficient plasma (congenital)
Factor VIII high plasma (acquired)
Factor VIII inhibitor plasma (Bethesda)
Factor X deficient plasma (acquired)
Factor X deficient plasma (congenital)
Factor X high plasma (acquired)
Factor XI deficient plasma (acquired)
Factor XI deficient plasma (congenital)
Factor XI high plasma (acquired)
Factor XII deficient plasma (acquired)
Factor XII deficient plasma (congenital)
Factor XII high plasma (acquired)
Factor XIII deficient plasma (acquired)
Factor XIII deficient plasma (congenital)
Free Protein S plasma
Heparin induced thrombocytopenia type 2 (HIT-2) positive serum
High antithrombin plasma
High fibrinogen plasma
High molecular weight kininogen (HMWK, Fitzgerald factor, factor XIV) deficient plasma (acquired)
High molecular weight kininogen (HMWK, Fitzgerald factor, factor XIV) deficient plasma (congenital)
Low fibrinogen plasma
Low molecular weight heparin (LMWH) plasma: Dalteparin (Fragmin)
Low molecular weight heparin (LMWH) plasma: Enoxaparin (Lovenox)
Low molecular weight heparin (LMWH) plasma: Fondaparinux (Arixtra)
Low molecular weight heparin (LMWH) plasma: Tinzaparin (Innohep)
Lupus anticoagulant plasma (dRVVT ratio, aPTT ratio), different titers
Non vitamin K antagonist/novel oral anticoagulant (NOAC) plasma: Apixaban (Eliquis)
Non vitamin K antagonist/novel oral anticoagulant (NOAC) plasma: Dabigatran (Pradaxa)
Non vitamin K antagonist/novel oral anticoagulant (NOAC) plasma: Rivaroxaban (Xarelto)
Normal plasma, healthy patients (thrombophilia ambulatory)
Oral anticoagulant plasma (warfarin, phenprocoumon), different INRs ranging from 1 - > 5
Plasminogen activator inhibitor-1 (PAI-1) plasma
Plasminogen deficient plasma (acquired)
Plasminogen deficient plasma (congenital)
Prekallikrein (Fletcher factor, factor XV) deficient plasma (acquired)
Prekallikrein (Fletcher factor, factor XV) deficient plasma (congenital)
Prekallikrein deficient plasma (acquired)
Prekallikrein deficient plasma (congenital)
Protein C deficient plasma (acquired)
Protein C deficient plasma (congenital)
Protein S deficient plasma (acquired)
Protein S deficient plasma (congenital)
Protein S high plasma
Prothrombin fragment 1.2 (PF 1.2 ) plasma
Prothrombin mutation G20210A (heterozygous), plasma
Prothrombin time (PT), pathological and normal, plasma
Resistance to activated protein C (aPCR), heterozygous, plasma
Resistance to activated protein C (aPCR), homozygous, plasma
Soluble fibrin monomer plasma
Thrombin time (TT) plasma, pathological and normal
Thrombin/antithrombin complex (TAT) plasma
Tissue plasminogen activator (t-PA)/Streptokinase therapy plasma
Unfractionated heparin (UFH) therapy plasma (activated partial thromboplastin time, aPTT)
Unfractionated heparin therapy plasma (anti-factor Xa level)
Vitamin K deficiency plasma
Von Willebrand disease type 1 (heterozygous quantitative defect), plasma
Von Willebrand disease type 2A (qualitative defect, reduced Ristocetin cofactor activity), plasma
Von Willebrand disease type 2M (qualitative defect in binding to GPIb), plasma
Von Willebrand disease type 2N (qualitative defect in binding to factor VIII), plasma
Von Willebrand disease type 3 (homozygous quantitative defect, total absence of vWF), plasma
Von Willebrand factor (vWF) activity, ristocetin cofactor activity, vWF:Rco, plasma
Von Willebrand factor (vWF) deficient plasma
Von Willebrand factor (vWF) deficient plasma, immuno depleted
Von Willebrand factor antigen, vWF:Ag, plasma
Von Willebrand factor, elevated vWF concentration, plasma